Associated Papers
Aspartylglucosaminuria: Clinical Presentation and Potential Therapies.
Goodspeed K et al.
Journal of Child Neurology, 2021
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Komor AC et al.
Nature, 2016
27096365 (PubMed )
Supplement: NIHMS774092-supplement-1.pdf
Structural basis of aspartylglucosaminuria.
Saito S et al.
Biochemical and Biophysical Research Communications, 2008
Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations.
Saarela J et al.
Human Molecular Genetics, 2001
Aspartylglycosaminuria: biochemistry and molecular biology.
Aronson NN
Biochimica Et Biophysica Acta, 1999
Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation.
Mononen I et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 1993
Spectrum of mutations in aspartylglucosaminuria.
Ikonen E et al.
Proceedings of the National Academy of Sciences of the United States of America, 1991
Select a paper to view details